Early safety, tolerability, and efficacy of REGN5093 in patients (pts) with MET-altered advanced non-small cell lung cancer (aNSCLC) from a first in human (FIH) study Meeting Abstract
| Authors: | Cho, B. C.; Ahn, M. J.; Kim, T. M.; Kim, C.; Shim, B. Y.; Han, J. Y.; Drilon, A. E.; Lena, H.; Gomez, J. E.; Gray, J. E.; Awad, M.; Perez, J.; Navas, M.; Kaul, M.; Patel, S.; Gao, B.; Magnan, H.; Rietschel, P. |
| Abstract Title: | Early safety, tolerability, and efficacy of REGN5093 in patients (pts) with MET-altered advanced non-small cell lung cancer (aNSCLC) from a first in human (FIH) study |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1085 |
| Language: | English |
| ACCESSION: | WOS:000866211601435 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.annonc.2022.07.1296 |
| Notes: | Meeting Abstract: 1173P -- Source: Wos |
